Please login to the form below

Not currently logged in
Email:
Password:

JK Associates

This page shows the latest JK Associates news and features for those working in and with pharma, biotech and healthcare.

Fishawack acquires brand communications agency Healthcircle

Fishawack acquires brand communications agency Healthcircle

Fishawack also operates under four other brands, including Medical communications groups Fishawack Communications and Fishawack Facilitate, specialist publication and scientific services group Fishawack Indicia and US-based JK Associates.

Latest news

  • Fishawack undergoes management buyout Fishawack undergoes management buyout

    In recent years the agency's acquisitions have included UK med comms agency Facilitate, US group JK Associates and Swiss agency  Archimed..

  • Fishawack opens San Francisco office Fishawack opens San Francisco office

    Oliver Dennis, CEO of Fishawack, said: “Following the expansions of our east coast US team earlier this year when JK Associates joined the Group, the next logical step was to invest

  • Archimed drug safety specialists rebrand Archimed drug safety specialists rebrand

    It made its second US acquisition, JK Associates, in April 2014.

  • Fishawack buys JK Associates

    When we discussed the synergies between us it was obvious – Fishawack needed more depth in the US and JK needed a European-based team with greater resources.”. ... JK Associates president and CEO John (Zeke) Czekanski and COO Kevin Pawley will

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics